Skip to main contentSkip to main content
You have permission to edit this article.
Edit
breaking

Looking for omicron: How long until variant is found in U.S.?

  • Updated
  • 0

After a slow start, the United States has improved its surveillance system for tracking new coronavirus variants such as omicron, boosting its capacity by tens of thousands of samples per week since early this year.

Viruses mutate constantly. To find and track new versions of the coronavirus, scientists analyze the genetic makeup of a portion of samples that test positive.

They're looking at the chemical letters of the virus's genetic code to find new worrisome mutants, such as omicron, and to follow the spread of known variants, such as delta.

It's a global effort, but until recently the U.S. was contributing very little. With uncoordinated and scattershot testing, the U.S. was sequencing fewer than 1% of positive specimens earlier this year. Now, it is running those tests on 5% to 10% of samples. 

Moderna CEO Stephane Bancel caused worry in global markets with comments that the drugmaker's vaccine may not be as effective against the new Omicron variant. Francis Maguire reports.

Brazil and Japan joined the rapidly widening circle of countries to report cases of the omicron variant Tuesday, while new findings indicate the mutant coronavirus was already in Europe close to a week before South Africa sounded the alarm.

The Netherlands' RIVM health institute disclosed that patient samples dating from Nov. 19 and 23 were found to contain the variant. It was on Nov. 24 that South African authorities reported the existence of the highly mutated virus to the World Health Organization.

That indicates omicron had a bigger head start than previously believed.

A panel of U.S. health advisers on Tuesday narrowly backed a closely watched COVID-19 pill from Merck, setting the stage for a likely authorization of the first drug that Americans could take at home to treat the coronavirus.

The Food and Drug Administration panel voted 13-10 that the antiviral drug’s benefits outweigh its risks, including potential birth defects if used during pregnancy.

The Biden administration is expected to take steps in the coming days to toughen testing requirements for international travelers to the U.S., including both vaccinated and unvaccinated people, amid the spread of the new omicron variant of the coronavirus.

The precise testing protocols were still being finalized ahead of a speech by President Joe Biden planned for Thursday on the nation's plans to control the COVID-19 pandemic during the winter season, according to a senior administration official who said some details could still change.

Among the policies being considered is a requirement that all air travelers to the U.S. be tested for COVID-19 within a day of boarding their flight. Currently those who are fully vaccinated may present a test taken within three days of boarding.

The emergence of the new omicron variant and the world’s desperate and likely futile attempts to keep it at bay are reminders of what scientists have warned for months: The coronavirus will thrive as long as vast parts of the world lack vaccines.

0 Comments

Concerned about COVID-19?

* I understand and agree that registration on or use of this site constitutes agreement to its user agreement and privacy policy.

Related to this story

Most Popular

Recommended for you

Welcome to the Conversation

No name-calling, personal insults or threats. No attacks based on race, gender, ethnicity, etc. No writing with your caps lock on – it's screaming. Keep on topic and under 1,500 characters. No profanity or vulgarity. Stay G- or PG-rated.

Get up-to-the-minute news sent straight to your device.

Topics

Breaking News

News Alerts